Clinical Trials Logo

Postmenopause clinical trials

View clinical trials related to Postmenopause.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05831709 Recruiting - Postmenopause Clinical Trials

The Influence of Hormone Replacement Therapy and Supervised Exercise Training on Body Composition, Cardiovascular Risk and Insulin Sensitivity in Postmenopausal Women

OPERATE
Start date: May 12, 2023
Phase: N/A
Study type: Interventional

This trial investigates whether supervised training in combination with hormonal substitution therapy has an impact on body composition, cardiovascular risk and insulin sensitivity in postmenopausal women.

NCT ID: NCT04867109 Recruiting - Clinical trials for Endometrial Neoplasms

HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding

METRODEC
Start date: June 25, 2021
Phase:
Study type: Observational

This study aims to explore the sensitivity of an innovative marker, HE4, in the diagnosis approach of endometrial cancer in case of postmenopausal bleedings.

NCT ID: NCT04136093 Recruiting - Metabolic Syndrome Clinical Trials

Diet for the Maintenance of Weight Loss and Metabolic Health in Obese Postmenopausal Women

WELCOME
Start date: February 29, 2020
Phase: N/A
Study type: Interventional

The aim of the study will be comparing the effectiveness of two diets: moderate in fat with a high proportion of monounsaturated fatty acids (MUFAs) - the Mediterranean diet (MED) and 2) the low in fat and high in dietary fiber contents the dietary approaches to stop hypertension diet (DASH) on weight maintenance and cardiovascular risks following a recent body weight reduction in centrally obese postmenopausal women. The tested diets will be given ad libitum manner. Moreover, adherence to both prescribed weight-loss maintenance diets will be also evaluated by the plasma concentration of alkylresorcinols (AR) as a possible whole grain wheat/rye dietary biomarker and by the analysis of fatty acids profile in erythrocyte membranes as a dietary biomarker of a fatty acids consumption. The participants of this study will be 150 non-smoking, postmenopausal women with central obesity, who wished to lose weight and have at least one other criterion of metabolic syndrome. The intervention will include 3 phases: Phase I (weeks 1-8), weight loss dietary intervention with 700 kcal/d energy deficit, Phase II (week 9-32), weight loss maintenance intervention for those participants losing ≥10% initial body weight the MED or the DASH diet will be offered in a random manner. The control group will receive oral dietary recommendations based on the Harvard model "Healthy Eating Plate". After this 32 weeks period will be finished, the participants will be discharged to the community with no contact by study personnel, until the 52-weeks follow-up period (Phase III).

NCT ID: NCT03644329 Recruiting - Postmenopause Clinical Trials

Effect of Resistance Training Variable Manipulation in Postmenopausal Breast Cancer Survivors.

Start date: May 13, 2018
Phase: N/A
Study type: Interventional

This study intends to evaluate the impact of resistance training variable manipulation (intensity and volume) on body composition, fatigability and functional capacity in postmenopausal breast cancer survivors.